Clinical Research
An extensive variety of clinical research articles outlining the science of ketamine and ketamine treatment.
24 June 2020
Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories
Maladaptive reward memories (MRMs) are involved in the development and maintenance of acquired overconsumption disorders, such as harmful alcohol and drug use. The process of memory reconsolidation – where stored memories become briefly labile upon retrieval – may offer a means to disrupt MRMs and prevent relapse. However, reliable means for pharmacologically weakening MRMs in …
Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories Read More »
Learn more
24 March 2020
Ketamine in the Treatment of Depressive Episodes
The treatment of depressive episodes remains complicated by the long latency of antidepressant efficacy, insufficient response, and high risk of suicide. Ketamine and esketamine have been proposed as fast-acting substances able to overcome these impediments.Since the first randomized controlled trial in the year 2000, numerous studies have explored the antidepressant efficacy of ketamine and esketamine. …
Ketamine in the Treatment of Depressive Episodes Read More »
Learn more
24 March 2020
Registered clinical trials investigating ketamine for psychiatric disorders
As interest has grown in the potential psychiatric applications of ketamine, the number of registered clinical trials has grown substantially. Herein, we summarize and analyze clinical trials registered with ClinicalTrials.gov that assess the treatment of any psychiatric disorder with ketamine or ketamine enantiomers (e.g., S-ketamine, R-ketamine), with a focus on ongoing clinical trials. A ClinicalTrials.gov …
Registered clinical trials investigating ketamine for psychiatric disorders Read More »
Learn more
